[18F]-RoSMA-18-d6

N/A

Report date: 2025/11/28 15:16:24

NME

Base Information

Drug Name[18F]-RoSMA-18-d6

Drug Alias NameN/A

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Fluorine > 18FSmall molecules > Heterocyclic drugs +[5]

Mechanisms of ActionPositron-emission tomography enhancersCannabinoid CB2 receptor binders

TargetsCannabinoid CB2 receptor

Therapy Area/IndicationsAmyotrophic Lateral Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesEth Zurich

China Registration ClassN/A

Develop Information

Active CompaniesEth Zurich

Inactive CompaniesN/A

Active IndicationsAmyotrophic Lateral Sclerosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A